Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?
Crossref DOI link: https://doi.org/10.1007/s00296-016-3447-x
Published Online: 2016-03-02
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yadlapati, Sujani
Efthimiou, Petros
Text and Data Mining valid from 2016-03-02